Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference
Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in v...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2009-01, Vol.52 (2), p.322-328 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 328 |
---|---|
container_issue | 2 |
container_start_page | 322 |
container_title | Journal of medicinal chemistry |
container_volume | 52 |
creator | Temperini, Claudia Cecchi, Alessandro Scozzafava, Andrea Supuran, Claudiu T |
description | Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors. |
doi_str_mv | 10.1021/jm801386n |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66824190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66824190</sourcerecordid><originalsourceid>FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</originalsourceid><addsrcrecordid>eNpt0U9u1DAUBvAIgehQWHAB5A1ILFL8J3Ey7EahwIhWLBhUdtGL_aJ4cOzBdoTCCVhzMA7BSUjpqN2wsiz__D3LX5Y9ZfSMUc5e7ceaMlFLdy9bsZLTvKhpcT9bUcp5ziUXJ9mjGPeUUsG4eJidsDVjZV2IVfa7gdB5ZxTZuGHWASKSrRtMZ5IP8Yw0fjxAMNE74nvSDNaHNIA12jsk4PSCNRxgNBrJlzzATJowxwSWfEphUmkKGIlxZKP1sovku0kD2Ub_Yx6XQdvX5GpAR3ZDQCRXkDCQS29RTXa5dh2fBiQfMPk_P3-dO2_JDqbkR1xeNJJL-Ir_wBvT9xjQKXycPejBRnxyXE-zz2_Pd837_OLju22zuchBFCLlupJrJopaVwVfs1JUnLKqQ2A1SKp1iUxU2HNeKKVqrnTRFXo5pYJ3XFJeitPsxU3uIfhvE8bUjiYqtBYc-im2Uta8YGu6wJc3UAUfY8C-PQQzQphbRtvr8trb8hb77Bg6dSPqO3lsawHPjwCiAtsHcMrEW8cZlZJLdudAxXbvp-CWv_jPwL9fCrEu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66824190</pqid></control><display><type>article</type><title>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Temperini, Claudia ; Cecchi, Alessandro ; Scozzafava, Andrea ; Supuran, Claudiu T</creator><creatorcontrib>Temperini, Claudia ; Cecchi, Alessandro ; Scozzafava, Andrea ; Supuran, Claudiu T</creatorcontrib><description>Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm801386n</identifier><identifier>PMID: 19115843</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Columbus, OH: American Chemical Society</publisher><subject>Antihypertensive agents ; Biological and medical sciences ; Carbonic Anhydrase Inhibitors - chemistry ; Carbonic Anhydrase Inhibitors - pharmacology ; Cardiovascular system ; Catalytic Domain ; Chlorthalidone - chemistry ; Chlorthalidone - pharmacology ; Crystallography, X-Ray ; Indapamide - chemistry ; Indapamide - pharmacology ; Isoenzymes - chemistry ; Medical sciences ; Models, Molecular ; Pharmacology. Drug treatments ; Stereoisomerism ; Water - chemistry</subject><ispartof>Journal of medicinal chemistry, 2009-01, Vol.52 (2), p.322-328</ispartof><rights>Copyright © 2009 American Chemical Society</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</citedby><cites>FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm801386n$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm801386n$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21066261$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19115843$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Temperini, Claudia</creatorcontrib><creatorcontrib>Cecchi, Alessandro</creatorcontrib><creatorcontrib>Scozzafava, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><title>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors.</description><subject>Antihypertensive agents</subject><subject>Biological and medical sciences</subject><subject>Carbonic Anhydrase Inhibitors - chemistry</subject><subject>Carbonic Anhydrase Inhibitors - pharmacology</subject><subject>Cardiovascular system</subject><subject>Catalytic Domain</subject><subject>Chlorthalidone - chemistry</subject><subject>Chlorthalidone - pharmacology</subject><subject>Crystallography, X-Ray</subject><subject>Indapamide - chemistry</subject><subject>Indapamide - pharmacology</subject><subject>Isoenzymes - chemistry</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Pharmacology. Drug treatments</subject><subject>Stereoisomerism</subject><subject>Water - chemistry</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0U9u1DAUBvAIgehQWHAB5A1ILFL8J3Ey7EahwIhWLBhUdtGL_aJ4cOzBdoTCCVhzMA7BSUjpqN2wsiz__D3LX5Y9ZfSMUc5e7ceaMlFLdy9bsZLTvKhpcT9bUcp5ziUXJ9mjGPeUUsG4eJidsDVjZV2IVfa7gdB5ZxTZuGHWASKSrRtMZ5IP8Yw0fjxAMNE74nvSDNaHNIA12jsk4PSCNRxgNBrJlzzATJowxwSWfEphUmkKGIlxZKP1sovku0kD2Ub_Yx6XQdvX5GpAR3ZDQCRXkDCQS29RTXa5dh2fBiQfMPk_P3-dO2_JDqbkR1xeNJJL-Ir_wBvT9xjQKXycPejBRnxyXE-zz2_Pd837_OLju22zuchBFCLlupJrJopaVwVfs1JUnLKqQ2A1SKp1iUxU2HNeKKVqrnTRFXo5pYJ3XFJeitPsxU3uIfhvE8bUjiYqtBYc-im2Uta8YGu6wJc3UAUfY8C-PQQzQphbRtvr8trb8hb77Bg6dSPqO3lsawHPjwCiAtsHcMrEW8cZlZJLdudAxXbvp-CWv_jPwL9fCrEu</recordid><startdate>20090122</startdate><enddate>20090122</enddate><creator>Temperini, Claudia</creator><creator>Cecchi, Alessandro</creator><creator>Scozzafava, Andrea</creator><creator>Supuran, Claudiu T</creator><general>American Chemical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090122</creationdate><title>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</title><author>Temperini, Claudia ; Cecchi, Alessandro ; Scozzafava, Andrea ; Supuran, Claudiu T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antihypertensive agents</topic><topic>Biological and medical sciences</topic><topic>Carbonic Anhydrase Inhibitors - chemistry</topic><topic>Carbonic Anhydrase Inhibitors - pharmacology</topic><topic>Cardiovascular system</topic><topic>Catalytic Domain</topic><topic>Chlorthalidone - chemistry</topic><topic>Chlorthalidone - pharmacology</topic><topic>Crystallography, X-Ray</topic><topic>Indapamide - chemistry</topic><topic>Indapamide - pharmacology</topic><topic>Isoenzymes - chemistry</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Pharmacology. Drug treatments</topic><topic>Stereoisomerism</topic><topic>Water - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Temperini, Claudia</creatorcontrib><creatorcontrib>Cecchi, Alessandro</creatorcontrib><creatorcontrib>Scozzafava, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Temperini, Claudia</au><au>Cecchi, Alessandro</au><au>Scozzafava, Andrea</au><au>Supuran, Claudiu T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2009-01-22</date><risdate>2009</risdate><volume>52</volume><issue>2</issue><spage>322</spage><epage>328</epage><pages>322-328</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors.</abstract><cop>Columbus, OH</cop><pub>American Chemical Society</pub><pmid>19115843</pmid><doi>10.1021/jm801386n</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2009-01, Vol.52 (2), p.322-328 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_66824190 |
source | MEDLINE; American Chemical Society Journals |
subjects | Antihypertensive agents Biological and medical sciences Carbonic Anhydrase Inhibitors - chemistry Carbonic Anhydrase Inhibitors - pharmacology Cardiovascular system Catalytic Domain Chlorthalidone - chemistry Chlorthalidone - pharmacology Crystallography, X-Ray Indapamide - chemistry Indapamide - pharmacology Isoenzymes - chemistry Medical sciences Models, Molecular Pharmacology. Drug treatments Stereoisomerism Water - chemistry |
title | Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A00%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbonic%20Anhydrase%20Inhibitors.%20Comparison%20of%20Chlorthalidone%20and%20Indapamide%20X-ray%20Crystal%20Structures%20in%20Adducts%20with%20Isozyme%20II:%20When%20Three%20Water%20Molecules%20and%20the%20Keto%E2%88%92Enol%20Tautomerism%20Make%20the%20Difference&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Temperini,%20Claudia&rft.date=2009-01-22&rft.volume=52&rft.issue=2&rft.spage=322&rft.epage=328&rft.pages=322-328&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm801386n&rft_dat=%3Cproquest_cross%3E66824190%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66824190&rft_id=info:pmid/19115843&rfr_iscdi=true |